Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
08/21/2023 | -4.89% | HSBC | $13.8 → $14.2 | Maintains | Hold |
06/30/2023 | 33.96% | JP Morgan | $18 → $20 | Maintains | Overweight |
05/25/2023 | 20.56% | JP Morgan | $16 → $18 | Upgrades | Neutral → Overweight |
05/24/2023 | 27.26% | Benchmark | $15 → $19 | Maintains | Buy |
05/24/2023 | 23.91% | UBS | $18 → $18.5 | Maintains | Buy |
05/24/2023 | -3.55% | HSBC | $12.5 → $14.4 | Maintains | Hold |
05/24/2023 | 19.22% | B of A Securities | $15.2 → $17.8 | Maintains | Buy |
04/03/2023 | 20.56% | UBS | $17.5 → $18 | Maintains | Buy |
02/24/2023 | 0.47% | Benchmark | → $15 | Upgrades | Hold → Buy |
02/24/2023 | 13.86% | Nomura Instinet | $10 → $17 | Upgrades | Neutral → Buy |
02/24/2023 | 17.21% | UBS | → $17.5 | Upgrades | Neutral → Buy |
02/24/2023 | 13.86% | CLSA | $11 → $17 | Upgrades | Outperform → Buy |
01/11/2023 | 13.86% | JP Morgan | $10 → $17 | Maintains | Neutral |
11/24/2022 | -33.69% | HSBC | $9.6 → $9.9 | Maintains | Hold |
11/23/2022 | -23.64% | Goldman Sachs | $10.1 → $11.4 | Maintains | Neutral |
10/19/2022 | -17.62% | B of A Securities | $13.5 → $12.3 | Maintains | Buy |
09/29/2022 | -35.7% | HSBC | $10.1 → $9.6 | Maintains | Hold |
08/22/2022 | -19.62% | Credit Suisse | → $12 | Upgrades | Neutral → Outperform |
08/22/2022 | -26.99% | Citigroup | $7.8 → $10.9 | Upgrades | Sell → Neutral |
03/21/2022 | -7.57% | B of A Securities | $17 → $13.8 | Maintains | Buy |
02/24/2022 | -33.02% | Morgan Stanley | $15 → $10 | Downgrades | Overweight → Equal-Weight |
11/24/2021 | 13.86% | B of A Securities | $33 → $17 | Maintains | Buy |
11/19/2021 | — | Benchmark | Downgrades | Buy → Hold | |
09/29/2021 | — | New Street Research | Downgrades | Buy → Neutral | |
09/23/2021 | -26.32% | JP Morgan | → $11 | Downgrades | Overweight → Neutral |
09/03/2021 | 13.86% | UBS | $33 → $17 | Downgrades | Buy → Neutral |
08/19/2021 | 7.17% | Credit Suisse | $29 → $16 | Downgrades | Outperform → Neutral |
05/21/2021 | 121.03% | B of A Securities | $38 → $33 | Maintains | Buy |
04/15/2021 | — | JP Morgan | Upgrades | Neutral → Overweight | |
01/26/2021 | — | KeyBanc | Downgrades | Overweight → Sector Weight | |
11/16/2020 | 94.24% | UBS | $27 → $29 | Maintains | Buy |
11/16/2020 | 67.45% | Keybanc | $24 → $25 | Maintains | Overweight |
11/02/2020 | 60.75% | Keybanc | $22 → $24 | Maintains | Overweight |
09/28/2020 | -12.93% | Morgan Stanley | $17 → $13 | Downgrades | Equal-Weight → Underweight |
08/20/2020 | 33.96% | JP Morgan | $25 → $20 | Downgrades | Overweight → Neutral |
07/15/2020 | 100.94% | UBS | → $30 | Upgrades | Neutral → Buy |
05/28/2020 | 47.35% | Keybanc | $21 → $22 | Maintains | Overweight |
03/09/2020 | 0.47% | UBS | $9 → $15 | Maintains | Sell |
03/06/2020 | 33.96% | Nomura | → $20 | Upgrades | Neutral → Buy |
03/06/2020 | 33.96% | Citigroup | $13 → $20 | Upgrades | Neutral → Buy |
03/06/2020 | 40.66% | Keybanc | $19 → $21 | Maintains | Overweight |
02/05/2020 | -9.58% | Morgan Stanley | → $13.5 | Initiates Coverage On | → Equal-Weight |
01/28/2020 | -8.57% | B of A Securities | $11.5 → $13.65 | Reiterates | → Neutral |
01/21/2020 | 27.26% | Keybanc | $18 → $19 | Maintains | Overweight |
12/16/2019 | 20.56% | Keybanc | $14 → $18 | Maintains | Overweight |
11/25/2019 | -6.23% | CLSA | $13.7 → $14 | Downgrades | Buy → Outperform |
11/22/2019 | 9.18% | Macquarie | → $16.3 | Initiates Coverage On | → Outperform |
11/14/2019 | 7.17% | JP Morgan | $15 → $16 | Maintains | Overweight |
11/14/2019 | -6.23% | Keybanc | $12 → $14 | Maintains | Overweight |
08/05/2019 | -43.07% | Jefferies | → $8.5 | Initiates Coverage On | → Hold |
04/30/2019 | -26.32% | JP Morgan | $6.5 → $11 | Upgrades | Neutral → Overweight |
04/22/2019 | — | UBS | Downgrades | Neutral → Sell | |
04/05/2019 | -26.32% | Keybanc | $10 → $11 | Maintains | Overweight |
02/22/2019 | -60.48% | Macquarie | $7 → $5.9 | Downgrades | Outperform → Neutral |
02/19/2019 | — | B of A Securities | Downgrades | Buy → Neutral | |
01/23/2019 | -33.02% | Keybanc | → $10 | Upgrades | Sector Weight → Overweight |
10/12/2018 | -63.16% | UBS | $8 → $5.5 | Maintains | Neutral |
10/10/2018 | -59.81% | JP Morgan | → $6 | Downgrades | Overweight → Neutral |
What is the target price for Vipshop Holdings (VIPS)?
The latest price target for Vipshop Holdings (NYSE: VIPS) was reported by HSBC on August 21, 2023. The analyst firm set a price target for $14.20 expecting VIPS to fall to within 12 months (a possible -4.89% downside). 19 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Vipshop Holdings (VIPS)?
The latest analyst rating for Vipshop Holdings (NYSE: VIPS) was provided by HSBC, and Vipshop Holdings maintained their hold rating.
When is the next analyst rating going to be posted or updated for Vipshop Holdings (VIPS)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vipshop Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vipshop Holdings was filed on August 21, 2023 so you should expect the next rating to be made available sometime around August 21, 2024.
Is the Analyst Rating Vipshop Holdings (VIPS) correct?
While ratings are subjective and will change, the latest Vipshop Holdings (VIPS) rating was a maintained with a price target of $13.80 to $14.20. The current price Vipshop Holdings (VIPS) is trading at is $14.93, which is out of the analyst's predicted range.